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Abstract
Rationale:Granulocytic sarcoma (GS) is deﬁned as leukemia inﬁltration in any organ other than the bone marrow. GS rarely occurs
in the pancreas. Here, we present the ﬁrst report of GS in the pancreas on 18F-ﬂuorodexyglucose positron emission tomography/
computed tomography (18F-FDG PET/CT).
Patient concerns: A 19-year-old male patient with acute myeloid leukemia received a human leukocyte antigen-haploidentical
stem cell transplant as a second transplant while in second complete remission.
Interventions: After a second stem cell transplant, obstructive pancreatitis accompanied by a mass in the pancreatic head was
observed. FDG-PET/CT revealed abnormal activity in the head of the pancreas and the skin in the patient’s left breast area.
Diagnoses: Pathological examination demonstrated relapsed acute myeloid leukemia in both the lesions.
Outcomes: This is the ﬁrst report showing the 18F-FDG PET/CT ﬁndings of GS in the pancreas.
Lessons: 18F-FDG PET/CT may help determine the stage of GS.
Abbreviations: 18F-FDG PET/CT = 18F-ﬂuorodexyglucose positron emission tomography/computed tomography; CT =
computed tomography; GS = granulocytic sarcoma; SUV = standardized uptake value maximum.
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1. Introduction
Granulocytic sarcoma (GS) is deﬁned as leukemia inﬁltration in
any organ other than the bone marrow. GS of the pancreas is rare
presentation of acute myeloid leukemia relapse. Sometimes, it
occurs after allogeneic transplantation, presumably reﬂecting
weaknesses of graft-versus-leukemia effect in the extramedullary
tissues. Here, we present the ﬁrst report of GS in the pancreas on
18F-ﬂuorodexyglucose positron emission tomography/computed
tomography (18F-FDG PET/CT).
2. Case report
A 19-year-old male patient with acute myeloid leukemia received
a human leukocyte antigen-haploidentical stem cell transplant
as a second transplant while in second complete remission.
The conditioning regimen consisted of total body irradiation,
melphalan, ﬂudarabine, and cytarabine.
Five months after the transplant, he developed epigastric and
back pain, and a skin tumor appeared on the abdomen.
Laboratory analyses showed elevated amylase (935U/L) and
lipase (2547U/L) levels. CT revealed distension of the Wirsung
duct and swelling of the pancreas. Diffusion-weighted magnetic
resonance imaging demonstrated restricted diffusion in a portion
of the pancreatic head, corresponding to a pancreatic mass.
Abdominal skin biopsy and endoscopic ultrasound-guided ﬁne
needle aspiration of the pancreatic mass revealed tumor cells
positive for the myeloid marker myeloperoxidase and CD34, as
determined by immunohistological examination. Furthermore,
18F-FDG PET/CT was also performed. Although the blood
glucose level was not measured before the examination, in spite
of his steroid diabetes, 3 focal lesions (Fig. 1A) with moderate
metabolic activity were observed in the pancreatic head
(standardized uptake value maximum [SUV max], 3.5)
(Fig. 1B, CT; C, PET; D, fusion), in the skin in his left breast
area (SUV max, 2.6) (Fig. 1E, CT; F, PET; G, fusion), and in the
abdominal skin (SUV max, 1.5). A diagnosis of relapsed acute
myeloid leukemia involving the pancreas and the skin was made,
and salvage chemotherapy was consequently initiated.
3. Discussion
This is the ﬁrst report showing the 18F-FDG PET/CT ﬁndings of a
GS in the pancreas. The differential diagnosis between pancreatic
GS and other diseases using 18F-FDG PET/CT is limited when the
tumor is accompanied by obstructive pancreatitis. GS is deﬁned
as leukemia inﬁltration in any organ other than the bonemarrow.
GS develops in 9%of patients with acutemyeloid leukemia[1] and
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occurs in 5% to 7% of patients undergoing allogeneic
hematopoietic stem cell transplantation as a relapse.[2] Only
approximately 20 cases of pancreatic GS have been
reported.[3–15] In almost all cases, CT and/or magnetic resonance
imaging were performed, whereas the 18F-FDG PET/CT ﬁndings
remain unknown. The reported 18F-FDG PET uptake of GS
ranges between SUVmax 2.6 and 9.7,[16] which may overlap with
that in other pancreatic cancers and inﬂammatory responses.[17]
Because of these overlaps, it may be difﬁcult to distinguish GS
from other diseases if uptake is detected in the pancreas. In our
case, obstructive pancreatitis accompanied GS, possibly making
it more difﬁcult to distinguish malignancy from an inﬂammatory
response. Moreover, the uptake in the pancreas might have been
decreased by steroid diabetes in our case. Thus, while 18F-FDG
PET/CT may be useful to detect GS in the early stage, determine
the stage, and evaluate the treatment response,[18] if GS develops
in the pancreas, especially when accompanied by pancreatitis,
18F-FDG PET/CT shows limited usefulness for the diagnosis.
Accordingly, it is necessary to perform biopsy to conﬁrm the
diagnosis, similar to that performed in our case.
In conclusion, this is the ﬁrst report showing the 18F-FDG PET/
CT ﬁndings of GS in the pancreas; 18F-FDG PET/CT may help
determine the stage of GS.
4. Consent
Informed consent was signed by the patient for the publication of
this report and related images.
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